Who owns BLTE? 13F holders and whale ownership
BLTE is tracked across public portfolios in Whale Analyzer. This page answers who owns BLTE, which top funds are buying BLTE, aggregate disclosed value, and recent position changes based on public data.
Open interactive stock dashboardTop holders
| Investor | Reported value | Shares | Change |
|---|---|---|---|
| Joseph Edelman 13F portfolio Perceptive Advisors holdings | $24.2M | 152.0K | Reduced |
| Stanley Druckenmiller 13F portfolio Duquesne Family Office holdings | $16.9M | 106.1K | New |
How to read this page
Values are reported public positions from tracked investors and institutions. They are not real-time ownership totals for the company.
Related stock holder pages
- PRAX whale holders — PRAXIS PRECISION MEDICINES I
- CELC whale holders — CELCUITY INC
- ASND whale holders — ASCENDIS PHARMA A/S
- ROIV whale holders — ROIVANT SCIENCES LTD
- CNTA whale holders — CENTESSA PHARMACEUTICALS PLC
- RYTM whale holders — RHYTHM PHARMACEUTICALS INC
- SYRE whale holders — SPYRE THERAPEUTICS INC
- NUVL whale holders — NUVALENT INC
Learn more in Whale Analyzer Academy
Frequently asked questions
Who owns BLTE stock?
Whale Analyzer tracks 2 public institutional holders of BLTE with a combined reported value of $41.1M. See the holder table above for the largest tracked positions.
Which top funds are buying BLTE?
Check the "Change" column in the holders table above. "New" means a fresh position was initiated, "Added" means an existing position was increased, and "Reduced" or "Sold" indicates trimming.
What does 13F ownership mean for BLTE?
Use the interactive BLTE dashboard on Whale Analyzer for real-time holder analysis, or read our 13F Alpha Signals Guide.